home / stock / srga / srga news


SRGA News and Press, Surgalign Holdings Inc. From 11/23/20

Stock Information

Company Name: Surgalign Holdings Inc.
Stock Symbol: SRGA
Market: NASDAQ

Menu

SRGA SRGA Quote SRGA Short SRGA News SRGA Articles SRGA Message Board
Get SRGA Alerts

News, Short Squeeze, Breakout and More Instantly...

SRGA - Surgalign Holdings, Inc. Appoints Paul Lewicki, PhD to Board of Directors

DEERFIELD, Ill., Nov. 23, 2020 (GLOBE NEWSWIRE) -- Surgalign Holdings, Inc. (Nasdaq: SRGA), a global pure-play spine company focused on advancing spine surgery including through the application of digital technologies to improve patient outcomes, today announced the appointment of Paul Lewi...

SRGA - Surgalign Holdings and Aziyo Biologics Announce Expanded Distribution Agreement

DEERFIELD, Ill. and SILVER SPRING, Md., Nov. 16, 2020 (GLOBE NEWSWIRE) -- Surgalign Holdings, Inc. (Nasdaq: SRGA), a global pure-play spine company focused on advancing spine surgery including through the application of digital technologies to improve patient outcomes, and Aziyo Biologics, ...

SRGA - Surgalign EPS beats by $0.04, beats on revenue

Surgalign (SRGA): Q3 Non-GAAP EPS of -$0.11 beats by $0.04; GAAP EPS of -$0.36 misses by $0.21.Revenue of $27.93M (-2.7% Y/Y) beats by $3.08M.Press Release For further details see: Surgalign EPS beats by $0.04, beats on revenue

SRGA - Surgalign Holdings, Inc. Announces Third Quarter 2020 Results

DEERFIELD, Ill., Nov. 11, 2020 (GLOBE NEWSWIRE) -- Surgalign Holdings, Inc. (Nasdaq: SRGA), a global pure-play spine company focused on advancing spine surgery including through the application of digital technologies to improve patient outcomes, today reported operating results for the thi...

SRGA - Surgalign Holdings, Inc. Schedules Third Quarter 2020 Earnings Release for November 11, 2020

DEERFIELD, Ill., Nov. 11, 2020 (GLOBE NEWSWIRE) -- Surgalign Holdings, Inc. (Nasdaq: SRGA), a global pure-play spine company focused on advancing spine surgery, including through the application of digital technologies to improve patient outcomes, today announced it plans to release financi...

SRGA - Surgalign Holdings, Inc. Announces Date Change for Third Quarter 2020 Earnings Release and Conference Call

DEERFIELD, Ill., Nov. 05, 2020 (GLOBE NEWSWIRE) -- Surgalign Holdings, Inc. (Nasdaq: SRGA), a global pure-play spine company focused on advancing spine surgery, including through the application of digital technologies to improve patient outcomes, today announced that it is changing its ear...

SRGA - Surgalign Holdings, Inc. Schedules Third Quarter 2020 Earnings Call for November 6 and Virtual Investor Day for November 12, 2020

DEERFIELD, Ill., Oct. 30, 2020 (GLOBE NEWSWIRE) -- Surgalign Holdings, Inc. (Nasdaq: SRGA), a global pure-play spine company focused on advancing spine surgery, including through the application of digital technologies to improve patient outcomes, today announced its plans to release third ...

SRGA - Axogen, Inc. Reports Third Quarter 2020 Financial Results

ALACHUA, Fla., Oct. 29, 2020 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, today reported financial results and business highlights for the second quarter ended September 30, 2020. ...

SRGA - Surgalign Holdings, Inc. Announces Completion of Acquisition of Holo Surgical Inc. and its ARAI Digital Surgery Platform

Acquisition Delivers on Commitment to the Promise of Digital Surgery to Improve Patient Outcomes DEERFIELD, Ill., Oct. 23, 2020 (GLOBE NEWSWIRE) -- Surgalign Holdings, Inc. (Nasdaq: SRGA), a global pure-play spine company focused on advancing spine surgery including through the appl...

SRGA - Aziyo Biologics to price IPO on Oct. 7th; competitors include ABBV, MDT, SRGA and SYK

Aziyo Biologics, Inc. is slated to price its IPO on Wednesday, October 7th.From the prospectus:"We are a commercial-stage regenerative medicine company focused on creating the next generation of differentiated products and improving outcomes in patients undergoing surgery, concentrating on pa...

Previous 10 Next 10